|
DE60109924T2
(de)
|
2000-05-25 |
2006-02-09 |
Targacept, Inc. |
Heteroaryldiazabicycloalkane als liganden für den nikotinischen acetylcholin-rezeptor
|
|
US6624167B1
(en)
|
2000-08-04 |
2003-09-23 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
ES2275808T3
(es)
*
|
2001-02-06 |
2007-06-16 |
Pfizer Products Inc. |
Composiciones farmaceuticas para el tratamiento de trastornos del snc y otros trastornos.
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
SE0202430D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
SE0202465D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New compounds
|
|
WO2004029050A1
(en)
|
2002-09-25 |
2004-04-08 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
|
JP2006519208A
(ja)
*
|
2003-02-27 |
2006-08-24 |
ニューロサーチ、アクティーゼルスカブ |
新規ジアザビシクロアリール誘導体
|
|
EP1699802A1
(en)
*
|
2003-12-22 |
2006-09-13 |
AstraZeneca AB |
Nicotinic acetylcholine receptor ligands
|
|
TW200529860A
(en)
*
|
2003-12-22 |
2005-09-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
|
JP4824578B2
(ja)
|
2003-12-22 |
2011-11-30 |
メモリー・ファーマシューティカルズ・コーポレイション |
インドール類、１，２−ベンズイソオキサゾール類、および１，２−ベンゾイソチアゾール類、ならびにそれらの製造と使用
|
|
BRPI0506881A
(pt)
*
|
2004-02-04 |
2007-06-26 |
Neurosearch As |
derivado de arila diazabicìclica, composição farmacêutica, uso de um derivado de arila diazabicìclica, e, método de tratamento, prevenção ou alìvio de uma doença ou distúrbio ou condição de um corpo de animal vivo
|
|
CA2560741C
(en)
|
2004-03-25 |
2013-08-06 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
US7488737B2
(en)
|
2004-04-22 |
2009-02-10 |
Memory Pharmaceutical Corporation |
Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
|
|
JP2007538011A
(ja)
|
2004-05-07 |
2007-12-27 |
メモリー・ファーマシューティカルズ・コーポレイション |
１ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用
|
|
EP1802616B1
(en)
*
|
2004-10-15 |
2011-01-12 |
NeuroSearch A/S |
Novel azabicyclic aryl derivatives and their medical use
|
|
US7625924B2
(en)
|
2004-12-22 |
2009-12-01 |
Memory Pharmaceuticals Corporation |
Nicotinic alpha-7 receptor ligands and preparation and uses thereof
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
JP2009526776A
(ja)
*
|
2006-02-14 |
2009-07-23 |
ノイロサーチ アクティーゼルスカブ |
新規なジアザビシクロアルカン誘導体及びその医療上の使用
|
|
JP2007217370A
(ja)
*
|
2006-02-17 |
2007-08-30 |
Nard Inst Ltd |
ポジトロン断層撮影法および該方法に用いるポジトロン放出化合物
|
|
EP2029594B1
(en)
|
2006-05-23 |
2010-10-20 |
NeuroSearch A/S |
Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
|
|
US20100234349A1
(en)
|
2006-09-04 |
2010-09-16 |
Olsen Gunnar M |
Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
|
|
WO2008119710A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Neurosearch A/S |
Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
|
|
SA08290475B1
(ar)
*
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
FR2931677B1
(fr)
*
|
2008-06-02 |
2010-08-20 |
Sanofi Aventis |
Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs
|
|
FR2931823B1
(fr)
|
2008-06-02 |
2012-08-17 |
Sanofi Aventis |
Sel de fumarate du 1,4-diazabicyclo°3.2.2!nonane-carboxylate de 4-bromophenyle, ses formes cristallines, leur preparation et leur utilisation en therapeutique
|
|
EP2540297B1
(en)
|
2008-11-19 |
2015-04-08 |
Forum Pharmaceuticals Inc. |
Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
|
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
|
RU2011150248A
(ru)
*
|
2009-05-11 |
2013-06-20 |
Энвиво Фармасьютикалз, Инк. |
Лечение когнитивных расстройств с определенными рецепторами альфа-7 никотиновой кислоты в комбинации с ингибиторами ацетилхолинэстеразы
|
|
CN105837566B
(zh)
|
2010-05-17 |
2018-02-06 |
富瑞姆制药公司 |
(R)‑7‑氯‑N‑(奎宁环‑3‑基)苯并[b]噻吩‑2‑甲酰胺盐酸盐单水合物的晶型
|
|
EP3673906A1
(en)
*
|
2011-03-18 |
2020-07-01 |
Genzyme Corporation |
Glucosylceramide synthase inhibitors
|
|
EP2846796A4
(en)
|
2012-05-08 |
2015-10-21 |
Forum Pharmaceuticals Inc |
METHODS OF MAINTAINING, PROCESSING OR ENHANCING COGNITIVE FUNCTION
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
IL300090A
(en)
|
2020-07-24 |
2023-03-01 |
Genzyme Corp |
Pharmaceutical preparations containing VENGLUSTAT
|
